Search all medical codes

Estrogen receptor positive status [ER+]

ICD10CM code

Medical Policies and Guidelines for Estrogen receptor positive status [ER+]

Related policies from health plans

Enhertu (fam-trastuzumab deruxtecan-nxki)
Enhertu (fam-trastuzumab deruxtecan-nxki)
Faslodex (fulvestrant)
Gene Expression Profiling for Managing Breast Cancer Treatment
Margenza (margetuximab-cmkb)
Halaven (eribulin)
Ixempra (iIxabepilone)
Outpatient Alpha-Fetoprotein Testing
Perjeta (pertuzumab)
CG-GENE-22 Gene Expression Profiling for Managing Breast Cancer Treatment
CG-LAB-26 Outpatient Alpha-Fetoprotein Testing
Concert Genetic Oncology: Algorithmic Testing (PDF)

Similar Codes


ICD10CM codes

Z17.0 - Estrogen receptor positive status [ER+]
Z17.1 - Estrogen receptor negative status [ER-]
Z17 - Estrogen receptor status
Z19.1 - Hormone sensitive malignancy status
E28.0 - Estrogen excess
Z19 - Hormone sensitivity malignancy status
Z19.2 - Hormone resistant malignancy status
Z92.23 - Personal history of estrogen therapy
Z15.04 - Genetic susceptibility to malignant neoplasm of endometrium
Z79.81 - Long term (current) use of agents affecting estrogen receptors and estrogen levels

HCPCS codes

J1380 - Injection, estradiol valerate, up to 10 mg
J9179 - Injection, eribulin mesylate, 0.1 mg
G8875 - Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
S3854 - Gene expression profiling panel for use in the management of breast cancer treatment
G9097 - Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as
G9842 - Patient has metastatic disease at diagnosis
S4981 - Insertion of levonorgestrel-releasing intrauterine system
J1410 - Injection, estrogen conjugated, per 25 mg
G0101 - Cervical or vaginal cancer screening; pelvic and clinical breast examination
S0170 - Anastrozole, oral, 1 mg

CPT4 codes

3315F - Estrogen receptor (ER) or progesterone receptor (PR) positive breast cancer (ONC)
3316F - Estrogen receptor (ER) and progesterone receptor (PR) negative breast cancer (ONC)
84233 - Receptor assay; estrogen
3395F - Quantitative non-HER2 immunohistochemistry (IHC) evaluation of breast cancer (eg, testing for estrog
3374F - AJCC Breast Cancer Stage I: T1c (tumor size > 1 cm to 2 cm) documented (ONC)
81500 - Oncology (ovarian), biochemical assays of two proteins (CA-125 and HE4), utilizing serum, with menop
3394F - Quantitative HER2 immunohistochemistry (IHC) evaluation of breast cancer consistent with the scoring
82671 - Estrogens; fractionated
0045U - Oncology (breast ductal carcinoma in situ), mRNA, gene expression profiling by real-time RT-PCR of 1
82672 - Estrogens; total